Clinical Trials Browser

Phase NA × Epstein-Barr Virus Infections × Biopsy × Clear all

NCT06870435 2025-03-11

Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyngeal Carcinoma in High-risk Areas

Phase NA Recruiting

68,649 enrolled

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections